JP2010510194A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510194A5
JP2010510194A5 JP2009536745A JP2009536745A JP2010510194A5 JP 2010510194 A5 JP2010510194 A5 JP 2010510194A5 JP 2009536745 A JP2009536745 A JP 2009536745A JP 2009536745 A JP2009536745 A JP 2009536745A JP 2010510194 A5 JP2010510194 A5 JP 2010510194A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
butanol
composition according
gelling agent
bisphosphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009536745A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510194A (ja
Filing date
Publication date
Priority claimed from EP06291785A external-priority patent/EP1923049A1/en
Priority claimed from EP06291786A external-priority patent/EP1923050A1/en
Application filed filed Critical
Priority claimed from PCT/EP2007/062472 external-priority patent/WO2008059059A1/en
Publication of JP2010510194A publication Critical patent/JP2010510194A/ja
Publication of JP2010510194A5 publication Critical patent/JP2010510194A5/ja
Pending legal-status Critical Current

Links

JP2009536745A 2006-11-17 2007-11-16 ビスホスホネート化合物を含む薬剤組成物 Pending JP2010510194A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US86629406P 2006-11-17 2006-11-17
US86630606P 2006-11-17 2006-11-17
EP06291785A EP1923049A1 (en) 2006-11-17 2006-11-17 Pharmaceutical compositions comprising a bisphosphonate compound
EP06291786A EP1923050A1 (en) 2006-11-17 2006-11-17 Liquid pharmaceutical compositions comprising a bisphosphonate compound
PCT/EP2007/062472 WO2008059059A1 (en) 2006-11-17 2007-11-16 Pharmaceutical compositions comprising a bisphosphonate compound

Publications (2)

Publication Number Publication Date
JP2010510194A JP2010510194A (ja) 2010-04-02
JP2010510194A5 true JP2010510194A5 (enExample) 2011-01-13

Family

ID=38895592

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009536745A Pending JP2010510194A (ja) 2006-11-17 2007-11-16 ビスホスホネート化合物を含む薬剤組成物
JP2009536746A Pending JP2010510195A (ja) 2006-11-17 2007-11-16 ビスホスホネート化合物を含む液体薬剤組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009536746A Pending JP2010510195A (ja) 2006-11-17 2007-11-16 ビスホスホネート化合物を含む液体薬剤組成物

Country Status (9)

Country Link
US (2) US20080167271A1 (enExample)
EP (2) EP2088996A1 (enExample)
JP (2) JP2010510194A (enExample)
AR (2) AR064263A1 (enExample)
AU (2) AU2007321108A1 (enExample)
CA (2) CA2669489A1 (enExample)
IL (2) IL198678A0 (enExample)
TW (2) TW200831130A (enExample)
WO (2) WO2008059060A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007321108A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
AU2010278860B2 (en) * 2009-07-31 2016-05-26 Thar Pharma, Llc Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
US12377149B2 (en) 2018-06-01 2025-08-05 The University Of North Carolina At Chapel Hill Injectable thermoresponsive hydrogels as a combinatory modality for controlled drug delivery, biomaterial implant and 3D printing bioink

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
MX21453A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
WO2000028982A2 (en) * 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
US20050074487A1 (en) * 1999-12-16 2005-04-07 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
CN1180846C (zh) * 2000-05-05 2004-12-22 霍夫曼-拉罗奇有限公司 含有双膦酸或其盐的,用于皮下给药的凝胶体状药物组合物
CN1633300A (zh) * 2002-02-14 2005-06-29 山之内制药株式会社 透皮制剂
JP4394888B2 (ja) * 2002-02-14 2010-01-06 救急薬品工業株式会社 経皮投与製剤
AU2004257674A1 (en) * 2003-07-11 2005-01-27 Macrochem Corporation Pharmaceutical compositions for topical application
MY141763A (en) * 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
WO2005037157A1 (en) * 2003-10-14 2005-04-28 Dermatrends, Inc. Enhancing transdermal administration of hydrophilic drugs
AU2007321108A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound

Similar Documents

Publication Publication Date Title
JP2010510194A5 (enExample)
ES2274236T3 (es) Complejos novedosos de esteres de acidos grasos de polihidroxialcanos y nacinamida.
ES2213916T3 (es) Un sistema de administracion transdermica de farmacos para un agente analgesico antiinflamatorio que comprende sal de dietilamonio de diclofenaco, y su metodo de fabricacion.
JP2009102342A5 (enExample)
CN101663022A (zh) 局部药物制剂
BG107493A (bg) 'ъ''ав на лак за нок'и
JP2018507914A5 (enExample)
HRP20191806T1 (hr) Transdermalni pripravci ibuprofena i postupci za njihovu uporabu
JP2014530242A5 (enExample)
JPWO2009037855A1 (ja) 口腔用及び皮膚用組成物
WO2005087195A3 (en) Novel compositions for topical delivery
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
TW201609200A (zh) 含水型貼劑
ES2457519T3 (es) Pasta a base de agua que contiene diclofenaco sódico
JP2012508256A5 (enExample)
ES2755728T3 (es) Parche con oclusión ajustable
AR064263A1 (es) Composiciones farmaceuticas que comprenden un compuesto bisfosfato
CA2583876A1 (en) A transmucosal veterinary composition comprising detomidine
JP2010500284A5 (enExample)
JP2009503097A5 (enExample)
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
JP2008088189A5 (enExample)
JP2009511630A (ja) ヒドロキシオリゴカルボン酸エステル:神経に対する作用と皮膚及び粘膜皮膚の器官又は部位への利用法
JP2007519703A5 (enExample)
JP2008533079A5 (enExample)